Oncolytics Biotech Inc. focuses on the discovery and development of pharmaceutical products for the treatment of cancer.Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent. The company was incorporated in 1998 and is headquartered in Calgary, Canada.
